Literature DB >> 26180315

Pulmonary and extrapulmonary features in bronchopulmonary dysplasia: a comparison with healthy children.

Naciye Vardar-Yagli1, Deniz Inal-Ince1, Melda Saglam1, Hulya Arikan1, Sema Savci2, Ebru Calik-Kutukcu1, Ugur Ozcelik3.   

Abstract

[Purpose] The aim of this study was to compare functional capacity and peripheral muscle strength in preterm children with bronchopulmonary dysplasia (BPD) with those of age-matched full-term healthy controls.
[Subjects and Methods] Eighteen BPD subjects and 20 healthy subjects were enrolled in the study. Pulmonary function testing was performed. Body composition was determined using the skinfold method. An analysis of posture was scored. Muscle strength was evaluated using a dynamometer. Functional capacity was assessed using the six-minute walking test (6MWT).
[Results] Pulmonary function testing parameters, 6MWT distance, and quadriceps strength of the children with BPD were significantly lower than those of healthy peers. The scores of posture analysis of the children with BPD were significantly higher than those of healthy subjects. Exercise heart rate was significantly higher in the children with BPD compared to healthy children. The 6MWT distance correlated with height, fat-free mass, exercise dyspnea perception, and hand grip strength in BPD children.
[Conclusion] The study showed that preterm children with BPD had disturbed pulmonary and extrapulmonary characteristics. BPD had lower fat free mass, reduced lung function, worsen postural function, a shorter 6MWT distance, and lower quadriceps strength than healthy children. These features may provide insights into the choice of outcome measures for pulmonary rehabilitation for BPD.

Entities:  

Keywords:  Bronhopulmonary dysplasia; Functional capacity; Lung function

Year:  2015        PMID: 26180315      PMCID: PMC4499978          DOI: 10.1589/jpts.27.1761

Source DB:  PubMed          Journal:  J Phys Ther Sci        ISSN: 0915-5287


INTRODUCTION

Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants1). BPD begins in the neonatal period but its effects can continue long term, through to adulthood. Premature infants with BPD have an increased rate of hospitalization for respiratory illness and need for respiratory medications, compared to those without BPD2). Adverse respiratory outcomes are one of the important long-term morbidities in survivors following prematurity. Lung function of preterm children is lower than normal, and those who also suffer from BPD have an even greater reduction in lung function. They have reduced forced expiratory flows (lower forced expiratory volume in one second [FEV1]) with normal forced vital capacity (FVC) and total lung capacity (TLC); higher residual volume (RV) and RV/TLC ratio; and show airway obstruction and air trapping as compared to healthy infants born at term3). Functional residual capacity and ventilation inequality are independently associated with the use of supplemental oxygen4, 5). Intermittent positive pressure ventilation, prolonged oxygen therapy, and maternal smoking are the main risk factors of reduced lung function in childhood period of BPD6). Respiratory problems can lead to a reduction in the functional exercise capacity of children with BPD who were born prematurely. Studies have shown that children born prematurely have functional capacity impairment with expiratory flow limitation and increased oxygen consumption during exercise, compared with children born at full term7). However, some studies with small sample sizes demonstrated that maximal cardiopulmonary exercise testing parameters were similar in preterm children with and without BPD7, 8). The discrepancy in the findings may be explained by the use of different exercise testing protocols. Children and adolescents with BPD participate in daily physical activities without symptoms2). Children with BPD at preterm frequently present delayed growth and undernutrition9,10,11). Vogt et al. suggested that preterm children may have muscular deconditioning due to their significantly reduced workload compared to healthy subjects12). Pathological changes in the neonatal period contribute to reduced lung function through the use of oxygen supplementation and the duration of mechanical ventilation. Whether, BPD with preterm birth is also associated with diminished functional exercise capacity and muscle strength later in life is not yet known. The aim of this study was to compare pulmonary and extrapulmonary features (functional capacity and peripheral muscle strength) of children with BPD with those of age-matched full-term controls.

SUBJECTS AND METHODS

This cross-sectional study was conducted with two groups of children aged 6–13 years. The group of BPD children comprised children with gestational ages of less than 32 weeks and/or a birth weight under 1,500 g. Bronchopulmonary dyplasia was identified by the need for oxygen supplementation for at least 28 days and chronic changes on chest radiography13). All patients received a standard medical treatment in the postnatal period. The BPD children with neurologic disorders like cerebral palsy and cognitive deficits (n=5) were excluded due to the difficulty of performing exercise tests and muscle strength measurements with such subjects. Therefore, 18 subjects with BPD (10 females, 8 males) were enrolled. The control group comprised 20 healthy subjects (12 females, 8 males) who were born at full-term after more than 37 weeks of gestation, and had no medical history of cardiac, pulmonary or muscular disorders, and were volunteers from among the relatives of researchers and staff. The protocol was approved by the Committee for Ethics in Research of the Hacettepe University. Written informed consent was received from all the children and their parents. Physical and demographic characteristics of the subjects were recorded. Data from the postnatal period regarding the use of mechanical ventilation or non-invasive ventilation, such as nasal continuous positive airway pressure and supplemental oxygen were recorded. Body mass index (BMI) was calculated by the formula of weight/height2 (kg/m2). Fat free mass (FFM), fat mass (FM), and percentage of body fat were determined using the skinfold thickness method from four (biceps, triceps, subscapular, and suprailiac) different regions using a skinfold caliper (Skinfold Caliper, Holtain Ltd., Crosswell, UK). Measurements were repeated three times on the dominant side and the mean of the three measurements was used14). Pulmonary function testing was performed using a spirometer (SensorMedics, 6200 Body Box, Viasys, USA). The FVC, FEV1, FEV1/FVC ratio, peak expiratory flow (PEF), and forced expiratoryflow from 25 to 75% (FEF25–75%) were recorded and expressed as percentages of the expected values in accordance with a subject’s age, height, body weight and gender15). Peripheral muscle strength (quadriceps, shoulder abductor and hand grip strength) was evaluated using a hand held digital dynamometer (JTECH, Medical Commander Powertrack II, USA). Measurements were repeated three times on the dominant side16). The highest value of the measurements was recorded in Newtons (N). The peripheral muscle strength values were expressed as the percentages of predicted values calculated using reference equations17). Functional exercise capacity was evaluated using the six-minute walking test (6MWT). The 6MWT was conducted in accordance with American Thoracic Society recommendations18). For the 6MWT, subjects were asked to walk back and forth along a 30-meter flat corridor as quickly as possible for six minutes. In the pre- and post-test periods, oxygen saturation was measured by a pulse oximeter (KPTS-01, Seoul, Korea). Heart rate, blood pressure, and respiratory rate were also recorded. Pre- and post-test fatigue and dyspnea perception were assessed using the Modified Borg Scale, which is a 0–10 point category scale19). Upon the completion of the test, the distance covered in the 6-minute walk was recorded in meters. The 6MWT was performed twice, separated an interval of half an hour, on the same day. For each patient, the longer walking distance of the two tests was used in the statistical analysis. The 6MWT distances were expressed as percentages of the expected values for the same age and gender20). Postural deformity was evaluated using the postural analysis form developed by Corbin et al. It consists of posterior and lateral observation of the severity of postural deformities. The score is classified as: 0=none, 1=mild, 2=moderate, and 3=severe21). Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) version 18.0 (SPSS Inc., Chicago, USA). Data normality was tested using the Kolmogorov-Smirnov test. Variables are expressed as mean±standard deviation, frequency, and percentages. Student’st test was used for the comparison of variables showing a normal distribution. The Mann-Whitney U test was used to compare non-parametric variables and those that did not showing a normal distribution. Discrete variables (gender) were compared using the χ2 test. Spearman’s rank correlation coefficient was used to investigate associations among the variables. Significance was accepted for values of p<0.05.

RESULTS

The subjects’ characteristics are shown in Table 1. All the children with BPD diagnosis had used oxygen supplementation for more than 28 days. Twelve (66.7%) children with BPD received surfactant and the support of mechanical ventilation in the neonatal period. Birth weight and gestational age were significantly lower in children with BPD than in healthy peers (p<0.05). Age, gender, and body mass of the children with BPD index were similar in the two groups (p>0.05). However, height, body weight, and fat-free mass were significantly lower than those of the healthy subjects (p<0.05, Table 1). No significant difference was found in body fat or percentage of body fat between the children with BPD and the healthy subjects (p>0.05).
Table 1.

Characteristics of BPD and healthy subjects

VariablesBPDn=18Healthyn=20
Age, years8.8±2.59.0±1.5
Gender, F/M10/812/8
Birth weight, g1,197.2±742.53,206.2±348.9*
Gestational age, weeks28.6±3.437.5±2.3*
Height, cm122.3±18.1140.1±14.4*
Body weight, kg25.9±12.236.6±13.6*
BMI, kg/m216.4±2.917.9±3.2
Fat free mass, kg15.5±3.228.9±10.8*
Body fat, kg4.2±1.98.5±5.2
Percentage of body fat, %16.3±6.121.5±8.1
Posture analysis
Lateral4.7±3.71.4±1.4*
Posterior2.5±2.30.4±0.7*
Total7.2±5.91.8±1.6*
Pulmonary function testing
FEV1, %78.0±21.298.0±11.7*
FVC, %98.0±14.198.3±10.5
FEV1/FVC73.7±13.191.1±5.9*
PEF, %87.1±14.286.5±17.6*
FEF25–75%, %57.0±25.9101.5±20.8*

*p<0.05; BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; PEF: peak expiratory flow; FEF25–75%: forced expiratory flow between 25% and 75%; PEF: peak expiratory flow rate.

*p<0.05; BMI: body mass index; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; PEF: peak expiratory flow; FEF25–75%: forced expiratory flow between 25% and 75%; PEF: peak expiratory flow rate. The FEV1, FEV1/FVC, PEF, and FEF25–75% were significantly lower in the children with BPD than in their healthy peers (p<0.05, Table 1), but FVC was similar between the two groups (p>0.05). Knee extensor strength and the percentage value of knee extensor strength were also significantly lower in the children with BPD than in the healthy subjects (p<0.05, Table 2). Knee extensor muscle strength correlated with BMI (r=0.717, p=0.02) in the children with BPD. There were no statistically significant differences in the strength of the shoulder abductor muscles and hand-grip strength between the two groups (p>0.05, Table 2).
Table 2.

Comparison of functional capacity and peripheral muscle strength of BPD and healthy subjects

VariablesBPDn=18Healthyn=20
6MWT distance, m532.8±100.0635.6±51.2*
%6MWT distance73.8±13.984.5±0.08*
Exercise heart rate, beats/min158.1±32.0138.7±29.2*
%maximal heart rate74.9±15.366.2±13.9
Exercise oxygen saturation, %96.3±2.097.7±1.1*
Systolic blood pressure, mmHg111.2±11.2107.2±19.5
Diastolic blood pressure, mmHg63.7±11.566.5±10.3
Respiratory rate, breaths/min33.0±5.430.0±5.3
Dyspnea, Borg0.7±1.60.1±0.4
Leg fatigue, Borg0.3±1.01.1±1.9
Quadriceps, N123.7±45.9177.5±55.0*
%Quadriceps59.4±16.778.6±22.5*
Shoulder abductors, N79.8±34.278.0±25.6
%Shoulder abductors74.7±15.670.1±22.6
Hand grip, N73.1±56.093.5±45.9
%Hand grip56.7±27.963.5±19.7

*p<0.05; 6MWT: six minute-walk test

*p<0.05; 6MWT: six minute-walk test The 6MWT distance and %6MWT distance were significantly lower in the children with BPD than in the healthy subjects (p<0.001 and p<0.01, respectively, Table 2). The 6MWT distances of 14 (77.6%) children with BPD were lower than the 95% confidence interval of the healthy subjects (611.7 to 635.7 m). The 6MWT distance correlated with height (r=0.607, p=0.048), fat-free mass (r=0.900, p=0.037), exercise dyspnea perception (r=0.646, p=0.005), and hand grip strength (r=0.609, p=0.047) in the children with BPD. Heart rate was higher and oxygen saturation was lower that achieved at the end of the exercise test in children with BPD compared to their healthy peers (p<0.05, Table 2). No statistically significant differences were found between the two groups in the percentage of maximal heart rate reached at the end of 6MWT test, systolic blood pressure, diastolic blood pressure, respiratory rate, dyspnea perception and perception of leg fatigue that were recorded during the test (p>0.05, Table 2). The lateral, posterior and total scores of analyses of posture were significantly higher in the children with BPD than in the healthy subjects (p<0.05, Table 1). The results show that 55.6% (n=10) of the children with BPD had mild to moderate complication of kyphosis; 33.3% (n=6) had mild to moderate lumbar lordosis; and 22.2% (n=4) had lateral deviation of the spine. Whereas, 25% (n=5) of healthy children had mild kyphosis; 20% (n=4) had mild lumbar lordosis; and 20% (n=4) had mild spinal curvature deviation (p<0.05).

DISCUSSION

In this study we showed that preterm children with BPD had disturbed pulmonary and extrapulmonary characteristics. The results of this study show that the preterm children with BPD had lower fat-free mass, reduced lung function, worsen postural function, walked a shorter in the 6MWT distance, and had lower quadriceps muscle strength than the healthy children. Nutritional status, as determined by height, weight, and fat-free mass, is impaired in children with BPD. Premature children with chronic lung disease frequently present delayed growth and under nutrition. Data on the body composition of 6- to 10-year olds is still lacking. It has previously been shown that children with BPD have increased total body water and decreased fat-free mass in the first year of their life22). Our study is the first study to demonstrate that fat-free mass is still lower than that of healthy controls at 6–10 years of age. Lung infections may lead to decreased energy intake. The medical treatment of preterm BPD, elevated resting metabolic rate, and increased work of breathing have been suggested as causes of the lower growth rates23,24,25,26). Preterm children with BPD have substantially reduced pulmonary function, a reflection of airway obstruction in the large and small airways which is the cause of significantly lower FEV1,FEV1/FVC, PEF, and FEF25–75%. Most studies have reported lung function impairment in young adults and children with BPD2, 8, 27). Duration of oxygen supplementation is associated with reduction in FEV15), and all of our BPD children used oxygen supplementation for a long time in the postnatal period. In our study, children with BPD who were born extremely preterm had lower peripheral muscle strength, especially in the lower extremities. This is the first study to report skeletal muscle function of children with BPD. One study that investigated the muscle strength of preterm children showed that there were significant differences in motor performance in the preterm group compared with healthy term subjects reflected by aerobic capacity, strength, endurance, flexibility, and activity level at 17 years of age28). The authors explained this reduction in leg power and hand-grip strength was result of reduced participation in physical activities. In our study, the lower extremity muscle function was related to the body mass index; therefore it might also explain delayed growth. The 6MWT is a simple, efficient, accurate, and safe method of measuring functional capacity at submaximal levels of exertion in children. Functional capacity evaluated using the 6MWT was lower in the children with BPD (532.9±100.0 m) than healthy peers (635.7±51.3 m). Tsopanoglou et al. also showed that premature children with BPD walked shorter distances in the 6MWT (480.9 ±80.5 m vs. 518.3±51.8 m, p <0.01) than full term children7). The longer walking distance of our study was probably due to the fact that our study group was older than the subjects of the study by Tsopanoglou et al. Hospitalization of BPD children may reduce functional capacity in BPD. Vrijlandt et al. reported that preterms with BPD had decreased maximal aerobic capacity and lower anaerobic threshold, which might be explained by a ventilatory or oxygen uptake limitation8). We found relationships between functional capacity and height, fat-free mass, exercise dyspnea perception, and hand-grip strength. Therefore, the reduction in functional capacity might also be explained by the delayed growth of children with BPD. In the present study, children with BPD had a higher heart rate after a submaximal exercise test than the health subjects. Studies have shown that this difference could be associated with increased sympathetic nervous system action on the heart muscle7). It could also be explained by the low physical fitness levels of BPD children, but we did not record their physical activity habits. Walking a shorter distance with a higher heart rate may be an indicator of lower levels of physical activity in BPD. We observed oxygen desaturation after the exercise test in children with BPD, but it was not pronounced (<90%) in any of our BPD children. This finding could be related to changes in alveolar gas exchange and diffusion due to immaturity or bronchopulmonary dysplasia29). We did not observe any significant differences in exercise respiratory rate, systolic or diastolic blood pressure, perceived dyspnea or fatigue. We noticed that many of our BPD children appear to have poor posture compared with their healthy counterparts. The most frequent postural deformity observed in the children with BPD was increased kyphosis. Worsening spinal deformity is associated with deteriorating lung function. No previous study has investigated postural problems in children with BPD. Studies of cystic fibrosis, as a chronic lung disease, have shown that prolonged use of the accessory muscles of respiration and their ensuing hypertrophy, accompanied by a flexed position may result in alterations in body posture, typically increased thoracic kyphosis, chest diameter, shoulder elevation and protraction, and abdominal flexion30). There were some of limitations to this study which should be considered when interpreting the findings. We did not measure the physical activity levels of BPD children; therefore, we did not examine whether their physical activity level contributed to the results. This study was still valuable because it reports postural deformities and reductions in muscle strength for the first time in children with BPD. In conclusion, we showed that preterm children with BPD had disturbed pulmonary and extrapulmonary characteristics. Their pulmonary function was impaired indicating large and small airway dysfunction. They also had significant postural abnormalities, decreased fat-free mass as well as impaired quadriceps muscle strength, walked a shorter distance in the 6MWT than healthy children. These pulmonary and extrapulmonary features may provide insights for the selection of outcome measures for pulmonary rehabilitation programs for patients with BPD. Interventions for enhancing functional capacity and muscle strength of patients with BPD should be encouraged at an early age.
  22 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

Review 2.  Posture and cystic fibrosis.

Authors:  R Tattersall; M J Walshaw
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

3.  Lung function among infants born preterm, with or without bronchopulmonary dysplasia.

Authors:  Manuel Sanchez-Solis; Luis Garcia-Marcos; Vicente Bosch-Gimenez; Virginia Pérez-Fernandez; Maria D Pastor-Vivero; Pedro Mondéjar-Lopez
Journal:  Pediatr Pulmonol       Date:  2011-12-13

4.  Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence.

Authors:  Lex W Doyle; Brenda Faber; Catherine Callanan; Nicholas Freezer; Geoffrey W Ford; Noni M Davis
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

5.  Six-minute walk test in children and adolescents.

Authors:  Ralf Geiger; Alexander Strasak; Benedikt Treml; Klaus Gasser; Axel Kleinsasser; Victoria Fischer; Harald Geiger; Alexander Loeckinger; Joerg I Stein
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

6.  Respiratory health in prematurely born preschool children with and without bronchopulmonary dysplasia.

Authors:  E J L E Vrijlandt; H M Boezen; J Gerritsen; E F Stremmelaar; E J Duiverman
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

7.  Body composition in children with bronchopulmonary dysplasia predicted from bioelectric impedance and anthropometric variables: comparison with a reference dual X-ray absorptiometry.

Authors:  L Bott; L Béghin; E Gondon; R Hankard; V Pierrat; F Gottrand
Journal:  Clin Nutr       Date:  2006-05-05       Impact factor: 7.324

8.  Mechanisms of bronchopulmonary dysplasia.

Authors:  Antonia P Popova
Journal:  J Cell Commun Signal       Date:  2013-01-20       Impact factor: 5.782

9.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

10.  Growth and body composition in preterm infants with bronchopulmonary dysplasia.

Authors:  W A Huysman; M de Ridder; N C de Bruin; G van Helmond; N Terpstra; J B Van Goudoever; P J J Sauer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

View more
  1 in total

1.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.

Authors:  Daniel J C Berkhout; Hendrik J Niemarkt; Marc A Benninga; Andries E Budding; Anton H van Kaam; Boris W Kramer; Charlene M Pantophlet; Mirjam M van Weissenbruch; Nanne K H de Boer; Tim G J de Meij
Journal:  Pediatr Res       Date:  2017-11-22       Impact factor: 3.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.